ALB and diabetic kidney disease: Jazi, Maryam Foroutan et al. revealed that in a streptozotocin-induced DKD rat model, supplementation of FMOD could effectively inhibit the expression of TGF-β1 and significantly alleviate the pathological features of DKD, such as reduced urinary albumin excretion and alleviated glomerular injury [56].